Printed from Voxsanity (voxsanity.com.au) — NCT07184294 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Depression And Anxiety
Depression and Anxiety Trial, Recruiting
NCT07184294
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older at the time of signing consent
- People of any gender, race, or ethnicity are welcome to participate
- People who have already completed at least one cycle of chemotherapy before being recruited
- People whose anxiety level scores above 3 on a simple 0–10 anxiety rating scale (called a Visual Analog Scale)
- People who have at least six more chemotherapy infusion sessions scheduled ahead of them
- People who have had a standard blood test (called a complete blood count) done within the past 24 hours
Who may not be able to join:
- People whose blood platelet count (a measure of clotting cells) is below 20,000 (note: people taking blood-thinning medications are not automatically excluded — confirm with trial site)
- People whose absolute neutrophil count (a measure of infection-fighting cells) is below 500
- People who have received radiation therapy to any area of the body that would be massaged, within the past 90 days
- People currently using cold therapy devices on their hands or feet (such as cold gloves or cold socks) that cannot be removed during a massage session
- People who have had surgery on their foot, leg, head, neck, shoulder, hands, or arms within the past three months
- People who have rashes, open wounds, or skin conditions that could be made worse by massage
- People with known allergies to creams, lotions, or other substances that may be used during massage therapy sessions
- People with a known allergy to Bioton dual-purpose massage cream or any of its ingredients
- People with an ongoing, uncontrolled psychiatric condition (such as a mood disorder, anxiety disorder, psychosis, or substance use disorder) that the person's cancer care team determines would interfere with participation
- Current or former employees who are under the direct or indirect supervision of the principal investigator, a co-investigator, or the study manager (this is to prevent any pressure or undue influence on staff)
- People who are pregnant
- People who have cancer that has spread to the bones (bone metastasis)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
28 August 2025
Est. completion
28 November 2026
Where this trial is recruiting
🇺🇸 United States
Primary endpoints
Participation rate; Completion rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.